(GNVC:Consolidated Issue listed on NASDAQ Capital Market)
Former Senior Vice President - Corporate Development, GenVec, Inc.
|Age||Total Calculated Compensation||This person is connected to 48 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Mr. Thomas E. Smart, Tom served as Executive Chairman and Chief Executive Officer of Anaptys Biosciences, Inc., since April 2007. Mr. Smart served as Senior Vice President of Corporate Development of GenVec Inc., where he was responsible for directing GenVec Inc. business development, intellectual property and contracting functions. He served with GenVec Inc. from March 1995 to April 2003. He served as Chief Business Officer of XOMA Ltd. Since August 2003, Mr. Smart ...
910 Clopper RoadPhone: 240-632-0740
Gaithersburg, Maryland 20878
Board Members Memberships*
Former Executive Chairman and Chief Executive Officer
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Research and Development Committee
The University of Chicago
Stanford Graduate School of Business
The University of Chicago Booth School of Business
Stanford University Law school
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Hans Arwidsson Ph.D.||Chief Executive Officer and President|
Eurocine Vaccines AB
|Daniel J. O'Connor Esq.||Chief Executive Officer, President and Director|
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$393.6K||Compensation as of Fiscal Year 2014.|